A second opinion on the need for new warnings on attention deficit hyperactivity disorder (ADHD) drugs from the FDA advisory committee contradicts The Pediatric Advisory Committee recommendation.
Psychiatric Times Vol 23 No 5
According to recent estimates,chronic medical conditionsaccount for 7 of every 10 deathsin the United States and have been foundto severely limit daily functioning in morethan 1 of 10 Americans, or 25 millionpeople This tremendous disease burdenaccounts for most of the dollars spenton health care annually in the UnitedStates.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Treating Mental Illness During Pregnancy the Same as Any Medical Illness: In Conversation With Jennifer L. Payne, MD
3
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
4
The Use of Aripiprazole for Bipolar Disorder
5
